Impact of a pharmacist-led adalimumab biosimilar interchange protocol on order processing time

This study indicates that utilization of a pharmacist-led interchange protocol may improve the order processing time for biosimilars. Focused efforts could prioritize comparison of the rates of discontinuation for adalimumab products.

Authors

Institutions

Publication Details

Journal
American Journal of Health-System Pharmacy
Published
2026-03-11
DOI
https://doi.org/10.1093/ajhp/zxag072
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of a pharmacist-led adalimumab biosimilar interchange protocol on order processing time

Kiersi S. Harmon, Talie Newman, Jeryl Raju, Alexandra Ritenour
American Journal of Health-System Pharmacy
Biosimilars and Bioanalytical Methods
article

Impact of a pharmacist-led adalimumab biosimilar interchange protocol on order processing time

Kiersi S. Harmon, Talie Newman, Jeryl Raju, Alexandra Ritenour
article en

Abstract

This study indicates that utilization of a pharmacist-led interchange protocol may improve the order processing time for biosimilars. Focused efforts could prioritize comparison of the rates of discontinuation for adalimumab products.

American Journal of Health-System Pharmacy
Christus Health (US)
Openalex Percentile: Top 23%
Biosimilars and Bioanalytical Methods
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.